BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 20059345)

  • 1. Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action.
    Rubino F; Schauer PR; Kaplan LM; Cummings DE
    Annu Rev Med; 2010; 61():393-411. PubMed ID: 20059345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic surgery for type 2 diabetes.
    Ahn SM; Pomp A; Rubino F
    Ann N Y Acad Sci; 2010 Nov; 1212():E37-45. PubMed ID: 21732953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of remission of type 2 diabetes mellitus after laparoscopic gastric banding and bypass.
    Hamza N; Abbas MH; Darwish A; Shafeek Z; New J; Ammori BJ
    Surg Obes Relat Dis; 2011; 7(6):691-6. PubMed ID: 20688578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interpretation of the International Joint Statement on Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes].
    Zhang P; Zheng C
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):372-377. PubMed ID: 28440515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remission of type 2 diabetes after Roux-en-Y gastric bypass is associated with greater weight loss.
    Kadera BE; Lum K; Grant J; Pryor AD; Portenier DD; DeMaria EJ
    Surg Obes Relat Dis; 2009; 5(3):305-9. PubMed ID: 19460674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuro-modulation and bariatric surgery for type 2 diabetes mellitus.
    Spector D; Shikora S
    Int J Clin Pract Suppl; 2010 Feb; (166):53-8. PubMed ID: 20377665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion of failed gastric banding into four different bariatric procedures.
    Abu-Gazala S; Keidar A
    Surg Obes Relat Dis; 2012; 8(4):400-7. PubMed ID: 21937286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term outcomes for super-super obese (BMI > or =60 kg/m2) patients undergoing weight loss surgery at a high-volume bariatric surgery center: laparoscopic adjustable gastric banding, laparoscopic gastric bypass, and open tubular gastric bypass.
    Stephens DJ; Saunders JK; Belsley S; Trivedi A; Ewing DR; Iannace V; Capella RF; Wasielewski A; Moran S; Schmidt HJ; Ballantyne GH
    Surg Obes Relat Dis; 2008; 4(3):408-15. PubMed ID: 18243060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss.
    Gumbs AA; Modlin IM; Ballantyne GH
    Obes Surg; 2005 Apr; 15(4):462-73. PubMed ID: 15946423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The surgical treatment of type two diabetes mellitus.
    Pories WJ; Mehaffey JH; Staton KM
    Surg Clin North Am; 2011 Aug; 91(4):821-36, viii. PubMed ID: 21787970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of sleeve gastrectomy and Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus in morbidly obese subjects.
    Jiménez A; Casamitjana R; Flores L; Viaplana J; Corcelles R; Lacy A; Vidal J
    Ann Surg; 2012 Dec; 256(6):1023-9. PubMed ID: 22968072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is sleeve gastrectomy as effective as gastric bypass for remission of type 2 diabetes in morbidly obese patients?
    de Gordejuela AG; Pujol Gebelli J; García NV; Alsina EF; Medayo LS; Masdevall Noguera C
    Surg Obes Relat Dis; 2011; 7(4):506-9. PubMed ID: 21411376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric banding for the treatment of type 2 diabetes mellitus in morbidly obese.
    Brancatisano A; Wahlroos S; Matthews S; Brancatisano R
    Surg Obes Relat Dis; 2008; 4(3):423-9. PubMed ID: 18226973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roux-en-Y gastric bypass stands the test of time: 5-year results in low body mass index (30-35 kg/m(2)) Indian patients with type 2 diabetes mellitus.
    Lakdawala M; Shaikh S; Bandukwala S; Remedios C; Shah M; Bhasker AG
    Surg Obes Relat Dis; 2013; 9(3):370-8. PubMed ID: 23068107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bariatric surgery and bone disease: from clinical perspective to molecular insights.
    Folli F; Sabowitz BN; Schwesinger W; Fanti P; Guardado-Mendoza R; Muscogiuri G
    Int J Obes (Lond); 2012 Nov; 36(11):1373-9. PubMed ID: 22828943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laparoscopic adjustable gastric banding and laparoscopic sleeve gastrectomy: which has a place in the treatment of diabetes in morbidly obese patients?
    Nocca D
    Diabetes Metab; 2009 Dec; 35(6 Pt 2):524-7. PubMed ID: 20152738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bariatric surgery in patients with type 2 diabetes: benefits, risks, indications and perspectives.
    Scheen AJ; De Flines J; De Roover A; Paquot N
    Diabetes Metab; 2009 Dec; 35(6 Pt 2):537-43. PubMed ID: 20152741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of bariatric surgery to treat diabetes: current challenges and perspectives.
    Koliaki C; Liatis S; le Roux CW; Kokkinos A
    BMC Endocr Disord; 2017 Aug; 17(1):50. PubMed ID: 28797248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal changes in glucose and insulin homeostasis after biliopancreatic diversion and laparoscopic adjustable gastric banding.
    Alam I; Stephens JW; Fielding A; Lewis KE; Lewis MJ; Baxter JN
    Surg Obes Relat Dis; 2012; 8(6):752-63. PubMed ID: 22177976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of factors associated with durable remission of diabetes after Roux-en-Y gastric bypass.
    Chikunguwo SM; Wolfe LG; Dodson P; Meador JG; Baugh N; Clore JN; Kellum JM; Maher JW
    Surg Obes Relat Dis; 2010; 6(3):254-9. PubMed ID: 20303324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.